RecruitingNCT06343051

USCOM in Newly Diagnosed FGR Cases

Ultrasound Hemodynamic Assessment in Newly Diagnosed Fetal Growth Restriction: A Pilot Study


Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

100 participants

Start Date

Jul 2, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses a non-invasive ultrasound tool (USCOM — ultrasound cardiac output monitor) to measure blood flow and heart function in pregnant women newly diagnosed with fetal growth restriction — a condition where the baby is not growing as expected. The goal is to better understand what is happening in the mother's circulation when the baby is small. **You may be eligible if...** - You are pregnant in the third trimester (after about 28 weeks) - You have just been diagnosed with fetal growth restriction (your baby's estimated weight or belly measurement is below the 10th percentile) **You may NOT be eligible if...** - You are carrying multiple babies (twins, triplets, etc.) - Your baby has structural or chromosomal abnormalities - You have gestational diabetes or pre-existing diabetes Talk to your doctor to see if this trial is right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEUSCOM

Device that measures how much blood is being pumped in and out of the heart.


Locations(1)

Mount Sinai Hospital

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06343051


Related Trials